A Randomized, Double-Blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects with Generalized Refractory Myasthenia Gravis (GMG)
Administered By
Contributors
- Juel, Vern Charles Principal Investigator
Start/End
- January 15, 2014 - June 30, 2017